?Recombinant human ErbB3 / Her3 protein, C-His-Avi (HEK293)
重組人ErbB3/Her3蛋白
| 英文名稱 | Recombinant human ErbB3 / Her3 protein, C-His-Avi (HEK293) |
| 中文名稱 | 重組人ErbB3/Her3蛋白 |
| 別????名 | erbB-2 isoform 2; HER2 receptor; Erbb2 protein; CerbB2; c erb B2; C erbB 2; C-erbB2; CD340; Erb B2; erbb2; HER 2; Her-2; HER 2/neu; HER2; Her2/neu; Herstatin; MLN 19; MLN19; NEU; NEU Proto Oncogene; Neuro Glioblastoma Derived Oncogene Homolog; NGL; p185 ErbB2; p185erbB2; Receptor Protein Tyrosine Kinase ErbB2 Precursor; Receptor tyrosine protein kinase erbB 2; TKR1; Tyrosine kinase type cell surface receptor HER2; v erb b2 erythroblastic leukemia viral oncogene homolog 2 neuro/glioblastoma derived oncogene homolog (avian); ERBB2_HUMAN; Receptor tyrosine-protein kinase erbB-2; Metastatic lymph node gene 19 protein; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; Recombinant human ErbB3 / Her3 protein, C-His-Avi (HEK293)?? |
| 理論分子量 | 71.6kDa |
| 檢測分子量 | Due to glycosylation, the protein migrates to 90-100 kDa based on Tris-Bis PAGE result. |
| 性????狀 | Lyophilized powder |
| 濃????度 | ＞0.5 mg/ml |
| 物????種 | Human |
| 序????列 | 20-643/1342 |
| 純????度 | >95% as determined by Tris-Bis PAGE; >95% as determined by SEC-HPLC |
| 純化方法 | AC |
| 內毒素 | <1.0 EU/μg as determined by LAL |
| 表達系統 | HEK293 cell |
| 活性 | Not tested |
| 標簽 | C-His-Avi |
| 緩?沖?液 | Lyophilized from 0.22 um filtered solution in PBS (pH=7.4) with 5 mM DTT. Normally 5% trehalose is added as protectant before Lyophilization. |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產品介紹 | ? |
| 產品圖片 |
 Immobilized Human Her3 at 1ug/ml(100ul/Well). Dose response curve for Anti-Her3 Ab.,with the EC50 of 0.2ug/ml determined by ELISA.
 The purity of Her3 is greater than 95% as determined by SEC-HPLC.
 Recombinant Her3 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%
|
本產品僅供科研使用.請勿用于醫藥,不能用于臨床治療診斷使用！